M-SYMPATHOL
Anesthesia, General
Helse FonnaSmall moleculePhase 4 / ApprovedActive
B
63/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Anesthesia, General cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
RAMIFENTANYL Helse Fonna | Phase 4 | BBB |
PROPOFOL Helse Fonna | Phase 4 | BBB |
EPHEDRINE, ANHYDROUS Helse Fonna | Phase 4 | BB |
MIVACURIUM ION Helse Fonna | Phase 4 | BB |
Noradrenaline Helse Fonna | Phase 4 | BB |
Same molecule, other indications
M-SYMPATHOL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →